Posterior Reversible Encephalopathy syndrome in allogenic bone marrow transplantation: Case report in a reference hospital of Peru
DOI:
https://doi.org/10.35434/rcmhnaaa.2024.171.2084Keywords:
Posterior Leukoencephalopathy Syndrome, Transplantation, Allogenic Transplant, PeruAbstract
Posterior reversible encephalopathy syndrome (PRES) is a rare neurological complication of allogeneic stem cell transplantation (incidence of 1.1-22%). Usually presents as a disorder of consciousness or encephalopathy, associated in most cases with headache, visual disturbance, Hypertension and epileptic seizures. Literature describes the presence of PRES in patients who have received immunosuppressive agents after Hematopoietic Stem Cells transplantation, including cyclosporine, tacrolimus, and sirolimus, as well as chemotherapy such as cyclophosphamide, vincristine, methotrexate, L-aspar, among others. Two cases of hematological patients with PRES are presented, and a review of the literature on PRES after Hematopoietic Stem Cells transplantation.
Downloads
Metrics
References
Kim SJ, Im SA, Lee JW, Chung NG, Cho B, Kim HK, et al. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia. Pediatr Neurol. diciembre de 2012;47(6):436-42.
Ghali MGZ, Davanzo J, Leo M, Rizk E. Posterior reversible encephalopathy syndrome in pediatric patients: pathophysiology, diagnosis, and management. Leuk Lymphoma. octubre de 2019;60(10):2365-72.
Agarwal N, Rotz S, Hanna R. Medical emergencies in pediatric blood & marrow transplant and cellular therapies. Front Pediatr. 7 de febrero de 2023;11:1075644.
Hun M, Xie M, She Z, Abdirahman AS, Li C, Wu F, et al. Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size. Front Pediatr [Internet]. 2021 [citado 9 de febrero de 2024];9. Disponible en: https://www.frontiersin.org/articles/10.3389/fped.2021.678890
Nascimento AA de A, Soares KD, Almeida MCS de, Melo JCA de, Almeida ACP de, Torres DV de O, et al. Neurotoxicity presented by patients undergoing hematopoietic stem cell transplantation: a scoping review. Acta Paul Enferm. 12 de diciembre de 2022;35:eAPE00567.
Maffini E, Festuccia M, Brunello L, Boccadoro M, Giaccone L, Bruno B. Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. marzo de 2017;23(3):388-97.
Chen Q, Zhao X, Fu HX, Chen YH, Zhang YY, Wang JZ, et al. Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transplant. octubre de 2020;55(10):2035-42.
Turón-Viñas E, Badell I, Trabazo M, Morón G, Coca E, Brió S, et al. [Neurological complications in haematopoietic stem cell transplant patients]. Rev Neurol. 1 de septiembre de 2021;73(5):174-83.
Li K, Yang Y, Guo D, Sun D, Li C. Clinical and MRI Features of Posterior Reversible Encephalopathy Syndrome With Atypical Regions: A Descriptive Study With a Large Sample Size. Front Neurol. 24 de marzo de 2020;11:194.
Anderson RC, Patel V, Sheikh-Bahaei N, Liu CSJ, Rajamohan AG, Shiroishi MS, et al. Posterior Reversible Encephalopathy Syndrome (PRES): Pathophysiology and Neuro-Imaging. Front Neurol. 16 de junio de 2020;11:463.
Gao B, Lyu C, Lerner A, McKinney AM. Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years? J Neurol Neurosurg Psychiatry. enero de 2018;89(1):14-20.
Kapoor R, Simalti A, Kumar R, Yanamandra U, Das S, Singh J, et al. PRES in Pediatric HSCT: A Single-Center Experience. J Pediatr Hematol Oncol. agosto de 2018;40(6):433-7.
Behfar M, Babaei M, Radmard AR, Kooraki S, Farajifard H, Naji P, et al. Posterior Reversible Encephalopathy Syndrome after Allogeneic Stem Cell Transplantation in Pediatric Patients with Fanconi Anemia, a Prospective Study. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. diciembre de 2020;26(12):e316-21.
Veljanovska AP, Stojanoski Z, Chadievski L, Stavridis IP, Trajkova S, Cevreska L, et al. Posterior Reversible Encephalopathy Syndrome (PRES) in Children Undergoing Allogeneic Stem Cell Transplantation. Pril Makedon Akad Na Nauk Umet Oddelenie Za Med Nauki. 1 de mayo de 2019;40(1):81-6.
Fukuyama T, Tanaka M, Nakazawa Y, Motoki N, Inaba Y, Higuchi T, et al. Prophylactic treatment for hypertension and seizure in a case of allogeneic hematopoietic stem cell transplantation after posterior reversible encephalopathy syndrome. Pediatr Transplant. diciembre de 2011;15(8):E169-173.
Shash H, Aldaama S, Omer H, Alafghani S. Different Clinicoradiological Characteristics of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncology and Post-Bone Marrow Transplantation Cases: A Retrospective Study. Front Neurol [Internet]. 2022 [citado 9 de febrero de 2024];13. Disponible en: https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.836033
Racchiusa S, Mormina E, Ax A, Musumeci O, Longo M, Granata F. Posterior reversible encephalopathy syndrome (PRES) and infection: a systematic review of the literature. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. mayo de 2019;40(5):915-22.
Brady E, Parikh NS, Navi BB, Gupta A, Schweitzer AD. The imaging spectrum of posterior reversible encephalopathy syndrome: A pictorial review. Clin Imaging. 2018;47:80-9.
Jafari L, Behfar M, Tabatabaie S, Karamlou Y, Kashani H, Radmard AR, et al. Posterior Reversible Encephalopathy Syndrome in Pediatric Hematopoietic Stem Cell Transplantation with Beta Major Thalassemia: The Association between the PRES Occurrence and Class of Beta Major Thalassemia. Clin Transplant. 2024;38(1):e15164.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Susy Bazán-Ruiz, Miguel A. Vences, Guido Bendezú-Quispe, Alfredo Wong
This work is licensed under a Creative Commons Attribution 4.0 International License.
